C4 Therapeutics (CCCC) EBITDA Margin Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - | -5,071.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,071.00 |
| Dec 31, 2025 | 48,880.00 |
| Sep 30, 2025 | -13,065.00 |
| Jun 30, 2025 | -25,567.00 |
| Mar 31, 2025 | 57,776.00 |
| Dec 31, 2024 | 36,634.00 |
| Sep 30, 2024 | 8,160.00 |
| Jun 30, 2024 | 117,424.00 |
| Mar 31, 2024 | -6,066.00 |
| Dec 31, 2023 | 21,642.00 |
| Sep 30, 2023 | 24,910.00 |
| Jun 30, 2023 | -111,742.00 |
| Mar 31, 2023 | -43,022.00 |
| Dec 31, 2022 | -117,727.00 |
| Sep 30, 2022 | -19,403.00 |
| Jun 30, 2022 | 2,572.00 |
| Mar 31, 2022 | -16,684.00 |
| Dec 31, 2021 | 18,266.00 |
| Sep 30, 2021 | -3,302.00 |
| Jun 30, 2021 | -11,897.00 |
| Mar 31, 2021 | -10,908.00 |
| Dec 31, 2020 | -14,169.00 |
| Sep 30, 2020 | -7,029.00 |